Search | IOVS | ARVO Journals

Showing 1 – 20 of 68

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Web based, fully automated, deep learning segmentation of oxygen induced retinopathy

Sa Xiao; Felicitas Bucher; yue wu; Ariel Rokem; Cecilia S Lee; Kyle V Marra; Regis Fallon; Sophia Diaz-Aguilar; Edith Aguilar; Martin Friedlander; Aaron Y. Lee

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1223. doi:

ARVO Annual Meeting Abstract July 2018

Phase 2 Trial of Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2

Emily Y. Chew; Traci E Clemons; Glenn J Jaffe; Sina Farsiu; eleonora lad; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2605. doi:

ARVO Annual Meeting Abstract July 2018

Human Serum Metabolomics Study in Macular Telangiectasia Type 2

Sasha Woods; Michael Powner; Senthil Selvam; Kamron Khan; Robyn H Guymer; Jennifer Trombley; Catherine Egan; Martin Friedlander; Marcus Fruttiger

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3154. doi:

ARVO Annual Meeting Abstract July 2018

Modeling the cell specific origins of MacTel using a large patient iPSC-RPE library

Kevin Eade; Marin Gantner; sarah Victor; Regis Fallon; sarah harkins-perry; Alec Johnson; Christian Metallo; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4584. doi:

ARVO Annual Meeting Abstract July 2018

CxCl10 mediates CNTF inhibition of outer retinal neovascularization

Felicitas Bucher; Edith Aguilar; Kyle V Marra; Andreas Stahl; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5327. doi:

ARVO Annual Meeting Abstract July 2018

Rare variants in the phosphoglycerate dehydrogenase (PHGDH) gene in MacTel patients lead to decreased enzymatic activity

Regis Fallon; Jana Zernant; Takayuki Nagasaki; Marin Gantner; sarah harkins-perry; Kevin Eade; Rando Allikmets; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5409. doi:

ARVO Annual Meeting Abstract July 2018

Extracellular vesicles from endothelial colony forming cells as paracrine mediators of neurovasculotrophic repair of the retina

Kyle V Marra; Susumu Sakimoto; Salome Murinello; Edith Aguilar; Felicitas Bucher; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5489. doi:

Special Issue September 2017

Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2

PDF

Dibyendu Mukherjee; Eleonora M. Lad; Ryan R. Vann; Stephanie J. Jaffe; Traci E. Clemons; Martin Friedlander; Emily Y. Chew; Glenn J. Jaffe; Sina Farsiu; for the MacTel Study Group
TAGS: telangiectasis, diagnostic imaging, eye, optical coherence tomography, personal integrity, spectral-domain optical coherence tomography
Invest. Ophthalmol. Vis. Sci.. 2017; 58(6):BIO291-BIO299. doi: 10.1167/iovs.17-21834

ARVO Annual Meeting Abstract June 2017

CNTF treatment prevents development of pathological tuft formation in VLDLR -/- mice

Edith Aguilar; Felicitas Bucher; Mauricio Rosenfeld; Susumu Sakimoto; Salome Murinello; Marin Gantner; kevin eade; Sophia Diaz-Aguilar; Maki Kitano; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):189. doi:

ARVO Annual Meeting Abstract June 2017

Mitochondrial activity in the retina relies on glycolysis independent of substrate availability

Marin Gantner; kevin eade; Edith Aguilar; Mitchell Prins; Alec Johnson; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3013. doi:

ARVO Annual Meeting Abstract June 2017

Characterization of the neuroinflammatory response in the oxygen-induced retinopathy model of ischemic retinopathy

Kyle Marra; Salome Murinello; Felicitas Bucher; Edith Aguilar; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3462. doi:

ARVO Annual Meeting Abstract June 2017

MiR-30a-5p inhibition prevents neovascularization through CCL2 upregulation and microglia activation in a model of ischemic retinopathy

Salome Murinello; Yoshihiko Usui; Susumu Sakimoto; Maki Kitano; Edith Aguilar; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5383. doi:

ARVO Annual Meeting Abstract September 2016

Old player, new game: supplementing, rather than inhibiting, CCL2 may more effectively limit retinal neovascularization.

Salome Murinello; Peter D Westenskow; Edith Aguilar; Amelia Schrick; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3647. doi:

ARVO Annual Meeting Abstract September 2016

Bone marrow derived CX3CR1+ progenitors facilitate vascular repair in a murine model of ischemic retinopathy

Edith Aguilar; Susumu Sakimoto; Salome Murinello; Peter D Westenskow; Yoshihiko Usui; Felicitas Bucher; Maki Kitano; Daniel Feitelberg; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3652. doi:

ARVO Annual Meeting Abstract September 2016

Effects of human endothelial colony forming cells on oxygen induced retinopathy in various immune competent cell-depleted mice.

Susumu Sakimoto; Edith Aguilar; Valentina Marchetti; Salome Murinello; Yoshihiko Usui; Felicitas Bucher; Daniel Feitelberg; Jennifer K Trombley; Peter D Westenskow; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3654. doi:

ARVO Annual Meeting Abstract September 2016

Preventing pathological angiogenesis in the retina using a microRNA that regulates endothelial cell survival

Daniel Feitelberg; Felicitas Bucher; Peter D Westenskow; Edith Aguilar; Yoshihiko Usui; Salome Murinello; Carli M Wittgrove; Parissa Keshavarzian; Sara Weis; David Cheresh; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3655. doi:

ARVO Annual Meeting Abstract September 2016

Implications for iPS-based disease modeling: significant variability is observed in RPE cells differentiated from identical sources

Marin L Gantner; Jennifer Hazen; Valentina Lo Sardo; Kevin Eade; Mitchell Prins; Peter D Westenskow; Ashley Barnett; Alec Johnson; Kristin Baldwin; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6061. doi:

ARVO Annual Meeting Abstract September 2016

Retinal Cells Generate and Secrete Cytokines and Bioreactive Lipids that Promote Choriocapillaris Homeostasis

Peter D Westenskow; Salome Murinello; Daniel Feitelberg; Edith Aguilar; Leah C Byrne; John Gerard Flannery; Gary Siuzdak; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract September 2016

Reducing retinal oxidative metabolism to arrest progression of ischemic retinopathies

Liliana P Paris; Marin L Gantner; Peter D Westenskow; Tim U Krohne; Edith Aguilar; Yoshihiko Usui; Jennifer K Trombley; Daniel Feitelberg; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):103. doi:

ARVO Annual Meeting Abstract September 2016

Combined Cell and Gene Therapy towards the Treatment of Age-Related Macular Degeneration and Diabetic Retinopathy

Sabiha Hacibekiroglu; Iacovos P Michael; Peter D Westenskow; Brian Ballios; Nikolaos Mitrousis; Jingsheng Tuo; Chi-Chao Chan; Derek van der Kooy; Molly Shoichet; Martin Friedlander; Andras Nagy

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):525. doi:

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Web based, fully automated, deep learning segmentation of oxygen induced retinopathy

Phase 2 Trial of Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2

Human Serum Metabolomics Study in Macular Telangiectasia Type 2

Modeling the cell specific origins of MacTel using a large patient iPSC-RPE library

CxCl10 mediates CNTF inhibition of outer retinal neovascularization

Rare variants in the phosphoglycerate dehydrogenase (PHGDH) gene in MacTel patients lead to decreased enzymatic activity

Extracellular vesicles from endothelial colony forming cells as paracrine mediators of neurovasculotrophic repair of the retina

Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2

CNTF treatment prevents development of pathological tuft formation in VLDLR -/- mice

Mitochondrial activity in the retina relies on glycolysis independent of substrate availability

Characterization of the neuroinflammatory response in the oxygen-induced retinopathy model of ischemic retinopathy

MiR-30a-5p inhibition prevents neovascularization through CCL2 upregulation and microglia activation in a model of ischemic retinopathy

Old player, new game: supplementing, rather than inhibiting, CCL2 may more effectively limit retinal neovascularization.

Bone marrow derived CX3CR1+ progenitors facilitate vascular repair in a murine model of ischemic retinopathy

Effects of human endothelial colony forming cells on oxygen induced retinopathy in various immune competent cell-depleted mice.

Preventing pathological angiogenesis in the retina using a microRNA that regulates endothelial cell survival

Implications for iPS-based disease modeling: significant variability is observed in RPE cells differentiated from identical sources

Retinal Cells Generate and Secrete Cytokines and Bioreactive Lipids that Promote Choriocapillaris Homeostasis

Reducing retinal oxidative metabolism to arrest progression of ischemic retinopathies

Combined Cell and Gene Therapy towards the Treatment of Age-Related Macular Degeneration and Diabetic Retinopathy

To View More...

You must be signed into an individual account to use this feature.